Suchergebnisse - "Cariou, Bertrand"

PubPharm (2)

1

Effect of alirocumab on individuals with type 2 diabetes, high triglycerides, and low high-density lipoprotein cholesterol

enthalten in: Cardiovascular diabetology | 2020

von Colhoun, H. | Leiter, L. | Müller-Wieland, D. | +8

2

Design and rationale of the ODYSSEY DM-DYSLIPIDEMIA trial : lipid-lowering efficacy and safety of alirocumab in individuals with type 2 diabetes and mixed dyslipidaemia at high cardiovascular risk

enthalten in: Cardiovascular diabetology | 2017

von Müller-Wieland, D. | Leiter, L. | Cariou, B. | +9

CommentIn: Ann Transl Med. 2017 Dec;5(23 ):477. - PMID 29285510

1
[1]